Actionable news
0
All posts from Actionable news
Actionable news in RVNC: REVANCE THERAPEUTICS Inc,

Revance Therapeutics Inc.

GO

Average Recommendation: Buy Average Target Price: 45.00
Number of Ratings: 3 Current Quarters Estimate: -1.01
FY Report Date: 12 / 2015 Current Year's Estimate: -3.50
Last Quarter's Earnings: -0.71 Median PE on CY...

More